Psoriatic Arthritis

Celgene's apremilast (Otezla) was found to alleviate joint pain and inflammation during clinical trials.

Apremilast (Otezla) is the first oral therapy FDA approved to improve signs and symptoms, including physical functioning for patients with this condition.

A recent study compared the annual cost per treated patient for a health plan for patients taking etanercept, adalimumab, or infliximab.

Humira, Abbott's biggest seller, was recently approved by the FDA to treat ulcerative colitis.

A new study finds that patients with autoimmune diseases being treated with immunosuppressive drugs are not at an increased risk of developing shingles.